Next-Generation Gynecological Cancer Diagnostics Market Size is projected to reach USD 5.45 Billion by 2030, growing at a CAGR of 10.68%: Straits Research
The global next-generation gynecological cancer diagnostics market size was valued at USD 2.18 billion in 2021. It is expected to reach USD 5.45 billion by 2030, growing at a CAGR of 10.68% during the forecast period (2022–2030). During the forecast period, North America is most dominant in the global next-generation gynecological cancer diagnostics market.
New York, United States, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Uterine, ovarian, and cervical cervix cancers are the most common in women. Cervical cancer ranks fourth among women's cancers. Gynecological cancers result from epigenetic factors, inherited mutations, and transcriptional deviations. The genomic and molecular framework of gynecologic cancers is critical for developing effective biomarkers for detection and prevention, molecular profiling, and personalized treatment strategies. In the past, gynecological cancers were analyzed using Sanger sequencing, which examined tiny DNA fragments (DNA). Next-generation sequencing, microarray, and polymerase chain reaction have helped decipher gynecological cancers' molecular profiles.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/next-generation-gynecological-cancer-diagnostics-market/request-sample
Growing Lifestyle-Related Diseases and Product Development Drives the Global Market
Next-generation cancer diagnostic tests are expected to be in high demand due to the increasing prevalence of oncology diseases and the hectic lifestyle that has become more stressful due to the consumption of full drinks and smoking. The development of this industry segment is expected to be positively influenced throughout the forecast period because these tests are expected to allow for an early diagnosis of a variety of cancers and an accurate prognosis of the disease's progression.
Several large companies' development and introduction of new products are expected to impact this market significantly. For this market, this is a significant factor that is likely to lead to lucrative growth opportunities in the future. The companion diagnostics market is expected to be characterized by high-value growth opportunities over the forecast period due to the rapid development of companion diagnostics and their implementation in the delivery of personalized and advanced genomic medicine.
Growing Accuracy in Laboratory Tests Create Tremendous Opportunities
Advanced workflow systems and revenue generation are expected to increase as diagnostic laboratories and integrated during the forecast period. Automated laboratory systems are developed and implemented throughout the forecast period. There will be an increase in the number of technologically advanced products being commercialized due to this shift from traditional laboratory testing to rapid point-of-care testing. This will be due to the change from traditional laboratory testing to rapid point-of-care testing. Manufacturers will have many options in the market as a result of such factors.
Report Scope
Report Metric | Details |
Market Size | USD 5.45 Billion by 2030 |
CAGR | 10.68% (2022-2030) |
Historical Data | 2019-2020 |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Technology, Application, Cancer Type, Function , Region |
Geographies Covered | North America, Europe, Asia-Pacific, LAME and Rest of the World |
Key Companies Profiled/Vendors | Agilent Technologies, Inc., ARUP Laboratories, BGI Genomics, CENTOGENE N.V., F. Hoffmann-La Roche Ltd, Fulgent Genetics, Inc., Illumina, Inc., Invitae Corporation, Konica Minolta, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., OPKO Health, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc. |
Key Market Opportunities | Development of More Accurate Laboratory Test to Boost Market Opportunities |
Key Market Drivers | Increasing Prevalence of Lifestyle-Related Diseases to Support Market Growth |
Buy Now Full Report @ https://straitsresearch.com/buy-now/next-generation-gynecological-cancer-diagnostics-market
Regional Analysis
During the forecast period, North America is most dominant in the global next-generation gynecological cancer diagnostics market. It is anticipated that the market for cervical cancer diagnostics in North America will record profitable growth throughout the forecast period. This results from establishing various cancer care programs to assist lower-income demographics.
Asia-Pacific will record significant growth in the Next-generation gynecological cancer diagnostics market during the forecast period. It is anticipated to be one of the regions with the highest growth rate in this industry, and its growth is expected to occur at a profitable rate.
Key Highlights
The global next-generation gynecological cancer diagnostics market size was valued at USD 2.18 billion in 2021. It is expected to reach USD 5.45 billion by 2030, growing at a CAGR of 10.68% during the forecast period (2022–2030).
Based on product type, it is anticipated that the pap smear segment will contribute significantly to the market's overall growth during the forecast period.
Based on the application, it is anticipated that the diagnostic center segment will account for a considerable portion of the overall market during the forecast period.
North America dominates the forecast period's global next-generation gynecological cancer diagnostics market.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/next-generation-gynecological-cancer-diagnostics-market/request-sample
The key players in the global next-generation gynecological cancer diagnostics market include
Agilent Technologies, Inc.
ARUP Laboratories
BGI Genomics
CENTOGENE N.V.
F. Hoffmann-La Roche Ltd
Fulgent Genetics, Inc.
Illumina, Inc.
Invitae Corporation
Konica Minolta, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
OPKO Health, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Global Next-Generation Gynecological Cancer Diagnostics Market: Segmentation
By Technology
Next-Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays
By Application
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
By Function
Therapeutic Monitoring
Companion Diagnostics
Prognostics
Cancer Screening
Risk Analysis
By Region
North America
Europe
Asia-Pacific
LAMEA
TABLE OF CONTENT
Introduction
Market Definition
Market Scope
Research Methodology
Primary Research
Research Methodology
Assumptions & Exclusions
Secondary Data Sources
Market Overview
Report Segmentation & Scope
Value Chain Analysis: Next-Generation Gynecological Cancer Diagnostics Market
Key Market Trends
Drivers
Restraints
Opportunities
Porter’s Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of Substitution
Threat of New Entrants
Competitive Rivalry
Market Share Analysis
Technology Overview
Introduction
Market Size & Forecast
Next-Generation Sequencing
Market Size & Forecast
Protein Microarrays
Market Size & Forecast
Application Overview
Introduction
Market Size & Forecast
Biomarker Development
Market Size & Forecast
CTC Analysis
Market Size & Forecast
Regional Overview
Introduction
Market Size & Forecast
America
North America
U.S.
By Technology
By Application
Canada
By Technology
By Application
Mexico
By Technology
By Application
Latin America
By Technology
By Application
Europe
Market Size & Forecast
Germany
By Technology
By Application
France
By Technology
By Application
The U.K.
By Technology
By Application
Italy
By Technology
By Application
Spain
By Technology
By Application
Rest of Europe
By Technology
By Application
The Asia Pacific
Market Size & Forecast
Japan
By Technology
By Application
China
By Technology
By Application
Australia
By Technology
By Application
India
By Technology
By Application
South Korea
By Technology
By Application
Rest of Asia-Pacific
By Technology
By Application
The Middle East & Africa
Market Size & Forecast
Saudi Arabia
By Technology
By Application
South Africa
By Technology
By Application
Kuwait
By Technology
By Application
Rest of Middle East & Africa
By Technology
By Application
Company Profile
Agilent Technologies Inc
Company Overview
Financial Performance
Recent Developments
Product Portfolio
ARUP Laboratories
Company Overview
Financial Performance
Recent Developments
Product Portfolio
BGI Genomics
Company Overview
Financial Performance
Recent Developments
Product Portfolio
Conclusion & Recommendation
Acronyms & Abbreviations
Table of Content and Figure @ https://straitsresearch.com/report/next-generation-gynecological-cancer-diagnostics-market/toc
Market News
Jun 2022, Agilent Announces New Oligonucleotide Analysis Software for Biopharma Research
News Media
Here is All You Need to Know About Cancer
Precision Cancer Therapy has been Instrumental in the Growing Adoption of PGX Technologies
Have a Look at the Related Research Report
Neoantigen Cancer Vaccine Market: Information by Neoantigen Type (Synthetic Long Peptide, Tumour cell), Route of Administration (Intravenous, Transdermal), and Region — Forecast till 2030
Treatment Planning Systems And Advanced Image Processing Market: Information by Components (Treatment Planning Software), Technique (3D Image Reconstruction), and Region — Forecast till 2030
Radioligand Therapy Market: Information by Product (Approved Products, Potential Pipeline), Indication (Prostate Cancer), Biomarker, and Region — Forecast till 2030
Acellular Therapy Market: Information by Application (Cardiology, Hepatology, Neurology), Scaffold (Cell Laden Hydrogel), Disease (Cancer, Parkinsons), and Region — Forecast till 2030
Oncology Precision Medicine Market: Information by Product type (Diagnostics, Therapeutics), Applications (Breast cancer, Lung cancer), and Region — Forecast till 2030
Cancer Microbiome Sequencing Market: Information by Offering (Product, Service), End-User (Hospitals and Diagnostic Laboratories), and Region — Forecast till 2030
About Straits Research Pvt. Ltd.
StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
For more information on your target market, please contact us below:
Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)
Email: sales@straitsresearch.com
Follow Us: LinkedIn | Facebook | Instagram | Twitter